Extended‐release naltrexone for people with alcohol use disorder on therapeutic anticoagulation: A case series-Reference-Cited by-同舟云学术

Extended‐release naltrexone for people with alcohol use disorder on therapeutic anticoagulation: A case series

Published:2022-12 Issue:12 Volume:47 Page:2393-2396
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Ciraldo Katrina¹²,Seraydarian Manuel³,Gasper James⁴,DeFries Triveni³⁵,Martin Marlene³⁵^ORCID

Affiliation:

1. Department of Obstetrics, Gynecology, and Reproductive Sciences University of Miami Miami Florida USA

2. Department of Family Medicine and Community Health University of Miami Miami Florida USA

3. San Francisco General Hospital San Francisco California USA

4. Department of Family and Community Medicine San Francisco General Hospital San Francisco California USA

5. Department of Medicine University of California, San Francisco San Francisco California USA

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13800

Reference21 articles.

1. Substance Abuse and Mental Health Services Administration.Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS publication No. PEP21‐07‐01‐003 NSDUH series H‐56);2021.https://www.samhsa.gov/data/.

2. Use of Medications for Alcohol Use Disorder in the US

3. Trends in Alcohol-Induced Deaths in the United States, 2000-2016

4. Effect of extended‐release naltrexone on alcohol consumption: a systematic review and meta‐analysis

5. Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous opiates and behavior: 2022;Peptides;2023-11